Objective:

To provide a comprehensive overview of the diagnosis, treatment, and management of Chronic Lymphocytic Leukemia (CLL) for internists, emphasizing the importance of a multidisciplinary approach.

Key Findings:

• The treatment landscape for CLL has significantly improved over the past decade, enhancing patient outcomes.
• Flow cytometry is crucial for diagnosing CLL and differentiating it from other conditions, impacting treatment decisions.
• Watch-and-wait is a valid strategy for asymptomatic patients, but can be challenging for patient psychology and compliance.

Interpretation:

The advancements in CLL treatment necessitate a multidisciplinary approach to optimize patient outcomes and manage complications, with implications for internists in ongoing education.

Limitations:

• The psychosocial impact of the watch-and-wait approach may affect patient compliance and mental health, necessitating support strategies.
• Not all patients may have access to the latest therapies or multidisciplinary care, which can lead to disparities in treatment outcomes.

Conclusion:

Ongoing education and collaboration among healthcare providers, particularly internists, are essential to improve the management of CLL patients.